ConductScience.org, home

Paper19336554

Risk factors for triple-negative breast cancer in women under the age of 45 years.

Dolle JM and 6 others. Cancer Epidemiol Biomarkers Prev, 2009. Cited by 185 papers, by iCite.

Cite this record

ConductScience Library. Risk factors for triple-negative breast cancer in women under the age of 45 years. Papers, record 19336554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19336554

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Risk factors for triple-negative breast cancer in women under the age of 45 years.
PubMed
Journal
Cancer Epidemiol Biomarkers Prev
PubMed
Year
2009
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
185
iCite
Relative citation ratio, by iCite
4.72
iCite
Revised in PubMed
2026-01-28
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dolle JMJessica M
2Daling JRJanet R
3White EEmily
4Brinton LALouise A
5Doody DRDavid R
6Porter PLPeggy L
7Malone KEKathleen E

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Contraceptives, Oral, HormonalMajor topic
Adult
Case-Control Studies
Female
Humans
Middle Aged
Neoplasm Invasiveness
Erb-b2 Receptor Tyrosine Kinases
Receptors, Estrogen
Receptors, Progesterone
Risk Factors
Young Adult

Source PubMed

Download CSV of topics

Grants11

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
N01-PC35142NCI NIH HHSUnited StatesPubMedPubMed
R01 CA59736NCI NIH HHSUnited StatesPubMedPubMed
N01 PC035142NCI NIH HHSUnited StatesN01PC035142PubMedNIH RePORTER
N01 CP095671NCI NIH HHSUnited StatesN01CP095671PubMedNIH RePORTER
R01 CA041416NCI NIH HHSUnited StatesR01CA041416PubMedNIH RePORTER
R01 CA-41416NCI NIH HHSUnited StatesPubMedPubMed
R01 CA098858NCI NIH HHSUnited StatesR01CA098858PubMedNIH RePORTER
R01 CA059736NCI NIH HHSUnited StatesR01CA059736PubMedNIH RePORTER
N01 PC035142NCI NIH HHSUnited StatesN01PC035142PubMedNIH RePORTER
R01 CA0988858-03NCI NIH HHSUnited StatesR01CA098885PubMedNIH RePORTER
ZIACP010126NIHNIH RePORTER

Download CSV of grants

References52

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116846528Hormone-related risk factors for breast cancer in women under age 50 years by estrogen and progesterone receptor status: results from a case-control and a case-case comparison.Breast Cancer Res2006https://conductscience.org/library/papers/16846528PubMed
23740036Evidence for a protective effect of lactation on risk of breast cancer in young women. Results from a case-control study.Am J Epidemiol1986https://conductscience.org/library/papers/3740036PubMed
312749720Breast cancers among very young premenopausal women (United States).Cancer Causes Control2003https://conductscience.org/library/papers/12749720PubMed
417387718
Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry.
Cancer2007https://conductscience.org/library/papers/17387718PubMed
510752798Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status.Am J Epidemiol2000https://conductscience.org/library/papers/10752798PubMed
617036554Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis.Mayo Clin Proc2006https://conductscience.org/library/papers/17036554PubMed
710667465Risk of breast cancer according to the status of HER-2/neu oncogene amplification.Cancer Epidemiol Biomarkers Prev2000https://conductscience.org/library/papers/10667465PubMed
87932822Risk of breast cancer among young women: relationship to induced abortion.J Natl Cancer Inst1994https://conductscience.org/library/papers/7932822PubMed
912132871Breast cancer risk factors and HER2 over-expression in tumors.Cancer Detect Prev2001https://conductscience.org/library/papers/12132871PubMed
1016236738Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.N Engl J Med2005https://conductscience.org/library/papers/16236738PubMed
117916400Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group.Lancet1994https://conductscience.org/library/papers/7916400PubMed
1212087137Oral contraceptives and the risk of breast cancer.N Engl J Med2002https://conductscience.org/library/papers/12087137PubMed
1317129383Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342.Breast Cancer Res2006https://conductscience.org/library/papers/17129383PubMed
148533744Case-control study of oral contraceptive use and risk of breast cancer.Am J Epidemiol1996https://conductscience.org/library/papers/8533744PubMed
1510919738Body size, physical activity, and breast cancer hormone receptor status: results from two case-control studies.Cancer Epidemiol Biomarkers Prev2000https://conductscience.org/library/papers/10919738PubMed
164097941Breast cancer and reproduction.Lancet1970https://conductscience.org/library/papers/4097941PubMed
1712917485Breast cancer classification and prognosis based on gene expression profiles from a population-based study.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12917485PubMed
1817910759Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas.Breast Cancer Res2007https://conductscience.org/library/papers/17910759PubMed
1912829800Repeated observation of breast tumor subtypes in independent gene expression data sets.Proc Natl Acad Sci U S A2003https://conductscience.org/library/papers/12829800PubMed
2016341146Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma.Mod Pathol2006https://conductscience.org/library/papers/16341146PubMed

See all 52 referencesDownload CSV of references

Cited by123

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 185 citations.

PMIDTitleJournalYearIn PapersSource
42467122Differential effects of oral contraceptives on lymph node metastasis in breast cancer: role of tumor size as an effect modifier.J Mammary Gland Biol Neoplasia2026https://conductscience.org/library/papers/42467122PubMed
41681885Targeting the Tumor Microenvironment in Triple-Negative Breast Cancer: Emerging Roles of Monoclonal Antibodies and Immune Modulation.Cancers (Basel)2026https://conductscience.org/library/papers/41681885PubMed
41495862Molecular subtypes of breast cancer in Jamaican women: high prevalence of triple-negative and HER2 + disease.Breast Cancer Res2026https://conductscience.org/library/papers/41495862PubMed
41457233The aetiology of breast cancer subtypes: results from the Million Women Study.Breast Cancer Res2025https://conductscience.org/library/papers/41457233PubMed
41212350Suppression of NGALR impedes TNBC cell survival, proliferation, invasion, and migration through Akt/mTOR and JAK/STAT3 pathway inhibition.Clin Transl Oncol2026https://conductscience.org/library/papers/41212350PubMed
41102953Targeting Key Molecular Mechanisms in Triple-Negative Breast Cancer Therapies with Natural Compounds.Curr Pharm Des2026https://conductscience.org/library/papers/41102953PubMed
40248551Triple-Negative Breast Cancer: A Retrospective Study of 23 Cases in Morocco.Cureus2025https://conductscience.org/library/papers/40248551PubMed
39525552Reproductive Considerations for Patients with Early-Onset Breast Cancer.Curr Breast Cancer Rep2022https://conductscience.org/library/papers/39525552PubMed
39409110Macrophages: Key Players in the Battle against Triple-Negative Breast Cancer.Int J Mol Sci2024https://conductscience.org/library/papers/39409110PubMed
39329990Estrogen Regulated Genes Compel Apoptosis in Breast Cancer Cells, Whilst Stimulate Antitumor Activity in Peritumoral Immune Cells in a Janus-Faced Manner.Curr Oncol2024https://conductscience.org/library/papers/39329990PubMed
38884025Beyond Milk and Nurture: Breastfeeding's Powerful Impact on Breast Cancer.Geburtshilfe Frauenheilkd2024https://conductscience.org/library/papers/38884025PubMed
37800138The impact of poor metabolic health on aggressive breast cancer: adipose tissue and tumor metabolism.Front Endocrinol (Lausanne)2023https://conductscience.org/library/papers/37800138PubMed
37484262Mechanistic insight into the bioactivity of prodigiosin-entrapped lipid nanoparticles against triple-negative breast, lung and colon cancer cell lines.Heliyon2023https://conductscience.org/library/papers/37484262PubMed
37430191Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis.BMC Cancer2023https://conductscience.org/library/papers/37430191PubMed
37340476Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.Breast Cancer Res2023https://conductscience.org/library/papers/37340476PubMed
37296891Obesity and Fibrosis: Setting the Stage for Breast Cancer.Cancers (Basel)2023https://conductscience.org/library/papers/37296891PubMed
37231419Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer.Cancer Cell Int2023https://conductscience.org/library/papers/37231419PubMed
37223478Novel Combination Therapy for Triple-Negative Breast Cancer based on an Intelligent Hollow Carbon Sphere.Research (Wash D C)2023https://conductscience.org/library/papers/37223478PubMed
37152665Rosetta Stone for Cancer Cure: Comparison of the Anticancer Capacity of Endogenous Estrogens, Synthetic Estrogens and Antiestrogens.Oncol Rev2023https://conductscience.org/library/papers/37152665PubMed
36987503Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk.Breast Cancer (Dove Med Press)2023https://conductscience.org/library/papers/36987503PubMed

See all 123 cited byDownload CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
NR4A13164PubTator's text mininghttps://conductscience.org/library/genes/3164NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/19336554

GET https://conductscience.org/api/papers/v1/19336554/references?page=2